Skip to content

A randomized controlled study of cognitive intervention in patients with dementia after stroke

A randomized controlled study of cognitive intervention in patients with dementia after stroke

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000033570
Enrollment
Unknown
Registered
2020-06-05
Start date
2020-06-10
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia after stroke

Interventions

experimental group:traditional cognitive training combined with computerized cognitive training

Sponsors

Shandong Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients aged 6) 10; the score test indicated that two cognitive domains were damaged; ADL was abnormal (over 75 years old >= 25, under 75 years old >= 23); 7. Patients with consistent caregivers (> 3 days / week).

Exclusion criteria

Exclusion criteria: 1. Patients with other pathological brain diseases, such as vascular malformation, tumor, abscess, encephalitis or other common non ischemic brain diseases (such as multiple sclerosis), found on CT or MRI; 2. Patients with other types of cognitive impairment (including Alzheimer's disease, Parkinson's disease, Lewy body dementia, etc.) have been diagnosed clearly in the past; 3. Patients with brain white matter high signal Fazekas grade > 2; 4. Patients with brain atrophy with GCA grade > 2; 5. Patients with severe liver or kidney dysfunction (ALT value > 2 times the upper limit of normal value or ast value > 2 times the upper limit of normal value; creatinine > 1.5 times the upper limit of normal value); 6. Patients with severe heart failure; 7. Patients with confirmed or proposed acute coronary syndrome; 8. Patients with high-risk arrhythmias, such as: second or third degree atrioventricular block in sick sinus syndrome, tachycardia related syncope and atrial fibrillation caused by no pacemaker; 9. Other planned surgical operations or treatments may require termination of clinical observation; 10. Patients with severe non cardiovascular and cerebrovascular diseases whose expected survival time is less than 1 year; 11. Patients who are unable to understand and / or obey the research procedures and / or follow-up due to mental disorders and emotional disorders; 12. Patients with severe anxiety and depression (HAMD > 24, HAMA >= 29); 13. Patients with aphasia, blindness and deafness who are unable to complete neuropsychological assessment and other patients who are not considered suitable for the study by researchers.

Design outcomes

Primary

MeasureTime frame
MMSE;MoCA;Video EEG plus flash stimulation;DTI;

Countries

China

Contacts

Public ContactChuanqiang Qu

Shandong Provincial Hospital

drquchuanqiang@sina.com+86 13583138679

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026